Last $8.68 USD
Change Today -0.04 / -0.46%
Volume 61.6K
HRTX On Other Exchanges
Symbol
Exchange
NASDAQ CM
Berlin
As of 2:14 PM 09/23/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Toby Rosenblatt

Former Director, Chairman of Nominating & Governance Committee, Chairman of Compensation & Stock Option Committee and Member of Audit & Finance Committee, Heron Therapeutics, Inc.
AgeTotal Calculated CompensationThis person is connected to 59 board members in 13 different organizations across 29 different industries.

See Board Relationships
76--

Background*

Mr. Toby Rosenblatt serves as President of Pacific Four Investments. Mr. Rosenblatt has been President of Founders Investments Ltd., since 1999. He served as President of The Glen Ellen Company. He served as Chairman, The Presidio Trust (a Federal corporation) from 1997 to 2005. Mr. Rosenblatt serves as a Director of Metropolitan Series Fund Inc. and Metropolitan Series Fund II. He serves as a Director of State Street Research Mutual Funds and Met Life Metropolitan Series ...

Read Full Background

Corporate Headquarters*

123 Saginaw Drive
Redwood City, California 94063

United States

Phone: 650-366-2626
Fax: --

Board Members Memberships*

Independent Trustee of State Street Research Master Investment Trust
Director
Director
Trustee Nominee
Trustee Nominee
Independent Trustee Nominee
Former Director
Independent Trustee Nominee
Trustee Nominee
Former Director
Former Director
Trustee Nominee
Trustee Nominee of Blackrock Liquidity Funds
Trustee Nominee
Trustee Nominee
Independent Trustee Nominee
Director Nominee
Trustee Nominee
Independent Trustee Nominee
Trustee Nominee
Trustee Nominee
Trustee Nominee
1983-2011
Former Director, Chairman of Nominating & Governance Committee, Chairman of Compensation & Stock Option Committee and Member of Audit & Finance Committee
1990-N/A
Former Trustee
1992-Present
Director
1993-Present
Trustee
1994-Present
Independent Trustee
1994-Present
Trustee
2005-N/A
Former Trustee
2005-Present
Trustee
2005-N/A
Trustee and Member of Audit Committee
2005-N/A
Trustee and Member of Audit Committee
2005-N/A
Former Trustee and Member of Audit Committee
2005-N/A
Trustee
2005-Present
Trustee
2005-N/A
Trustee of BlackRock Fund
2005-Present
Trustee of Black Rock Funds
2005-Present
Trustee of Blackrock Funds
2005-N/A
Former Trustee of Blackrock Funds
2005-Present
Trustee of Blackrock Funds
2005-Present
Trustee of Blackrock Funds

Education*

There is no Education data available.

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
HRTX:US $8.68 USD -0.04

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Richard F. Pops Chairman of the Board and Chief Executive Officer
Alkermes plc
$810.2K
David M. Stack Chairman, Chief Executive Officer and President
Pacira Pharmaceuticals, Inc.
$916.2K
Alex Gorsky Chairman, Chief Executive Officer, Chairman of Executive Committee and Chairman of Finance Committee
Johnson & Johnson
$1.5M
Christopher A. Viehbacher Chief Executive Officer, Director and Member of Strategy Committee
Sanofi
€3.0M
Dov Tamarkin Ph.D.Co-Founder and Chief Executive Officer
Foamix Pharmaceuticals Ltd.
--
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact HERON THERAPEUTICS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.